What is LOPJLB’s current signal on GALT?

LOPJLB’s latest quantitative signal on Galectin Therapeutics Inc. (GALT) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is GALT in?

Galectin Therapeutics Inc. (GALT) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Galectin Therapeutics Inc. (GALT) do?

Galectin Therapeutics Inc. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and advancing new therapies for a spectrum of illnesses, including fibrotic disorders and various cancers. The company's flagship therapeutic agent is belapectin (GR-MD-02), an inhibitor of galectin-3, which is a complex polysaccharide polymer. This compound is currently undergo…

Where is Galectin Therapeutics Inc. based / listed?

Galectin Therapeutics Inc. is based in US, listed on NASDAQ.

Galectin Therapeutics Inc. (GALT)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$3.94+8.24%Close

SELLRECOVERY · day 1

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONEBEST

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $259M
Beta: 0.38
P/E (TTM): -8.81

Short % float: 19.62%
Days to cover: 33.7
SI change: -1.4%

1W: +1.03%
1M: +1.03%

vs SPY 1W: -0.13%
vs SPY 1M: -1.97%

Industry peers

FMP comparable companies · ranked by market cap

DRTSSELLAlpha Tau Medical Ltd$1.3BBEARQ 15$14.25+2.93%
LBRXSELLLB Pharmaceuticals Inc Common Stock$980MCRISISQ 80$34.16+7.54%
DSGNSELLDesign Therapeutics, Inc.$730MCRISISQ -12$11.69+1.39%
AURASELLAura Biosciences, Inc.$668MRECOVERYQ -6$6.46+0.46%
IMABI-Mab$542M$2.88
ALTSELLAltimmune, Inc.$517MCRISISQ -5$2.66+0.38%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news